Tafamidis for transthyretin amyloid cardiomyopathy: the solution or just the beginning of the end?
Author:
Affiliation:
1. Brigham and Women’s Hospital/Dana Farber Cancer Institute Amyloidosis Program, 75 Francis St, Boston, MA, USA
Publisher
Oxford University Press (OUP)
Subject
Cardiology and Cardiovascular Medicine
Link
http://academic.oup.com/eurheartj/article-pdf/40/12/1009/28170678/ehy697.pdf
Reference22 articles.
1. Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade;Bulawa;Proc Natl Acad Sci USA,2012
2. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy;Maurer;N Engl J Med,2018
3. Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial;Coelho;Neurology,2012
4. Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy);Cho;Amyloid,2015
5. AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin;Penchala;Proc Natl Acad Sci USA,2013
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prevalence and clinical outcomes of transthyretin amyloidosis: a systematic review and meta‐analysis;European Journal of Heart Failure;2022-08-02
2. Synthesis and Evaluation of Monoaryl Derivatives as Transthyretin Fibril Formation Inhibitors;Pharmaceutical Chemistry Journal;2022-03-31
3. Effect of Tafamidis on Serum Transthyretin Levels in Non-Trial Patients With Transthyretin Amyloid Cardiomyopathy;JACC: CardioOncology;2021-10
4. Estimating the health benefits of timely diagnosis and treatment of transthyretin amyloid cardiomyopathy;Journal of Comparative Effectiveness Research;2021-08
5. New drug approvals for 2019: Synthesis and clinical applications;European Journal of Medicinal Chemistry;2020-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3